Health Care Q4 Dividend Roundup: Merck Offers Thicker Dividend Cushion Than AbbVie [Seeking Alpha]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Seeking Alpha
MRK's dividend safety strengthens, with a projected DCR of 2.57x for 2026, surpassing both its historical average and ABBV's outlook. AbbVie (ABBV) maintains strong results but faces DCR pressure from CAPEX plans, with a projected 2.19x DCR in 2026. ABBV offers far lower forward P/E ratio than MRK (15.7x vs. 24.1x), but dividend yields suggest different valuation dynamics. This idea was discussed in more depth with members of my private investing community, Envision Early Retirement. Learn More » stanciuc/iStock via Getty Images MRK and ABBV stocks' FQ4 earnings I last covered AbbVie Inc. ( ABBV ABBV:CA ) on Jan 8, 2026, with an article titled “AbbVie: The Dividend Does Not Lie”. The article was triggered by ABBV's dividend More on my IG service As you can tell, our core style is to provide actionable and unambiguous ideas from our independent research. If your share this investment style, check out Envision Early Retirement. It provides at least 1x in-depth articles
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- Viokace (AbbVie) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]Yahoo! Finance
- AbbVie (ABBV) had its "buy" rating reaffirmed by Guggenheim.MarketBeat
- RBC Capital Says AbbVie Inc. (ABBV) Growth Story Is Still in Early Stages [Yahoo! Finance]Yahoo! Finance
- Josh Brown: Biotech growth stocks immune to disruption risk [Yahoo! Finance]Yahoo! Finance
- Market Downturn: 2 Stocks to Buy and Hold Through Any Storm [Yahoo! Finance]Yahoo! Finance
ABBV
Earnings
- 2/4/26 - Miss
ABBV
Sec Filings
- 3/11/26 - Form 4/A
- 3/9/26 - Form PRE
- 3/6/26 - Form 4
- ABBV's page on the SEC website